Sunday, July 29, 2018 12:40:42 PM
Who are these “ Shorts “ ? are they large investors that are in the know and while knowing there is no significant milestone , conclusion to a trial ending or event , like a conformation of partnership decision is confirmed , why hasn’t J&J committed yet ? They listed Imetelstat as one of top oncology drug , appear to be taking steps to launch in Denmark , & poss other EU countries , are these Shorts the longs waiting for the right time to cover based on inside knowledge ? Here’s why I ask , this really small Bio has a 600 plus Mil MC there are blogs set up just to discuss Imetelstat, J&J is invested in not just trials , they filed Patent Applications for Imetelstat as if they already own it ! Not all but it def plays into the idea by some there is more than just a little interest , that and J&J is not shy about listing Imetelstat as a top oncology drug , other large Pharm trials in combo with their drugs , checkout Imetelstatchat good info from some Docs
Recent GERN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 12:14:14 AM
- Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/14/2026 08:05:00 PM
- Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary • GlobeNewswire Inc. • 04/13/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 08:31:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 08:31:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 08:30:34 PM
- Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:37:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:33:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:32:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:18:10 PM
- Geron Announces Appointment of New Members to its Board of Directors • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/18/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 09:30:02 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/02/2026 12:47:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:11:02 PM
- Geron shares drop after Q4 results miss estimates despite Rytelo growth • IH Market News • 02/25/2026 03:39:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:15:13 PM
- Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Geron Plans to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 11:11:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 11:10:05 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/18/2026 09:15:00 PM
